MedWatch

Nuevolution CEO on million-dollar offer from Amgen: "It's the result of many years' work"

CEO in Danish Nuevolution, Alex Gouliaev, credits his employees for Amgen's offer to acquire the company for USD 167 million. He hopes that he and most staff members will continue their work under the new leadership, which is to speed up development in the Danish company.

Foto: Nuevolution PR

This week, US drug group Amgen offered to acquire all shares in Danish Nuevolution for USD 167 million.

The board of Nuevolution unanimously recommends that the shareholders accept the offer. The three major shareholders, who together own approximately 60 percent of the shares, have already said yes.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier